Katie Nichols, PA
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,506 of the $2,071 with a category attached, or 72.7%. 8 manufacturers reported payments, led by Stryker at 37.9% of the total. Reporting peaked in 2022 at $1,295 and has fallen 98.7% since, to $17 in 2024.
Across 23 payments — averaging $90.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$785
- Intuitive Surgical$552
- Myriad Genetic Laboratories, Inc.$288
- Medtronic$183
- Davol Inc.$157
- Otsuka Pharmaceutical Development & Commercialization, Inc.$62
- plus $44 from 2 others
What the payments were for
- Travel & lodging$56527%
- Food & beverage$1,50673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $785 |
| Intuitive Surgical | 8 | $552 |
| Myriad Genetic Laboratories, Inc. | 3 | $288 |
| Medtronic | 2 | $183 |
| Davol Inc. | 2 | $157 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $62 |
| Integra Lifesciences Corporation | 1 | $27 |
| Solventum Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPY-PHI SYSTEM$702
- myRisk$246
- Da Vinci Surgical System$222
- Signia$166
- PHASIX$121
How this compares
$2,071 in reported general payments places this provider in the 85th percentile of 78 surgical providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 19 | $197 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $82 |
Paid to pharmacies, not to this prescriber.
Other surgical in Nampa
- Boyd LaytonNampa$246
- Lauren GibsonNampa$221
- Bret PaulsonLewiston$14K
- Joseph FramptonTwin Falls$5K
- Michael NieraethBoise$5K
- Lance McKayPocatello$4K
- Shannon GardinerMeridian$4K
- Megan BrownBoise$3K
- Thomas EskelsenCoeur D Alene$3K
- Jeffrey GriggsBoise$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.